Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer

SIMPLE SUMMARY: The introduction of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of lung cancer. Nevertheless, TKI resistance impedes therapeutic efficacy and its underlying mechanisms remain unclear. This review summarizes the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingwei, Li, Peiyi, Shao, Jun, Liang, Shufan, Wan, Yuntian, Zhang, Qiran, Li, Changshu, Li, Yalun, Wang, Chengdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496789/
https://www.ncbi.nlm.nih.gov/pubmed/36139582
http://dx.doi.org/10.3390/cancers14184423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496789/
https://www.ncbi.nlm.nih.gov/pubmed/36139582
http://dx.doi.org/10.3390/cancers14184423

Ejemplares similares